The outcomes indicated that COPB2 expression levels were significantly associated with the clinical stage of the following cancer types: LIHC (P = 0.0165), OV (P = 0.0347), and SKCM (P = 0.0394) (Figure 1(d)). Here, COPB2 is linked to cancer.